Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Celularity Inks Research Collaboration with Regeneron | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Celularity Inks Research Collaboration with Regeneron

Celularity to provide research support for Regeneron’s targeted, allogeneic CAR T-cell therapy.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Celularity Inc., a biotechnology company developing allogeneic cell therapies and biomaterial products, has entered a multi-year research collaboration services agreement with Regeneron to support the research of Regeneron’s allogeneic cell therapy candidates.

The agreement’s initial focus is the research on a targeted allogeneic gamma delta chimeric antigen receptor (CAR) T-cell therapy owned by Regeneron designed to enhance proliferation and potency against solid tumors. The research will take place at Celularity’s state-of-the-art facility located in Florham Park, NJ. Financial terms were not disclosed.

“The agreement with Regeneron announced today is an important milestone for Celularity that recognizes our expertise in the research of cellular therapies, including the engineering of CAR-T cells. We believe that this relationship paves the way for future industry collaborations leveraging our world class cell therapy facilities and capabilities,” said Robert J. Hariri, M.D., Ph.D., Celularity’s CEO, chairman and founder. “We have long admired the exceptional scientific legacy at Regeneron and welcome the opportunity to collaborate with a world leader in innovative medicines.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics